Top Buy
Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Novavax Inc. | 6 | 2 | 4 | 1 | €12.15 | €49.80 | 309.911% |
EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €11.33 | €27.80 | 145.402% |
Cytokinetics Inc. | 26 | 1 | 3 | 0 | €53.50 | €84.57 | 58.078% |
Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
MacroGenics Inc. | 12 | 1 | 3 | 1 | €4.06 | €12.42 | 206.329% |
Evolus Inc | 9 | 0 | 2 | 0 | €11.60 | €20.43 | 76.142% |
Insmed Inc. | 15 | 1 | 2 | 1 | €23.60 | €42.72 | 80.998% |
Esperion Therapeutis.Inc. | 14 | 0 | 2 | 0 | €2.06 | €8.39 | 306.702% |
Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.22 | €11.05 | 111.470% |
AnaptysBio Inc | 9 | 1 | 2 | 0 | €22.00 | €45.21 | 105.500% |
Biolife Solutions Inc | 2 | 0 | 2 | 0 | €18.90 | €32.00 | 69.312% |
Heron Therapeutics Inc. | 10 | 1 | 1 | 0 | €2.58 | €4.58 | 77.679% |
Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.22 | €26.95 | 163.696% |
Akero Therapeutics Inc | 13 | 0 | 1 | 0 | €19.44 | €38.62 | 98.679% |
Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.76 | €4.16 | 136.836% |
Intra-Cellular Therapies Inc. | 24 | 0 | 1 | 0 | €61.50 | €79.55 | 29.357% |
Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €35.60 | €45.98 | 29.157% |
Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.04 | €24.13 | 60.460% |
Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.87 | €6.45 | 244.322% |
Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.92 | €13.77 | 1403.603% |
Anika Therapeutics | 5 | 0 | 1 | 0 | €23.60 | €28.29 | 19.876% |
Chromadex Corp | 11 | 2 | 1 | 0 | €3.16 | €5.58 | 76.449% |
Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €23.57 | €60.55 | 156.911% |
Verastem Inc. | 10 | 0 | 1 | 0 | €11.10 | €24.63 | 121.935% |
MannKind Corp. | 8 | 0 | 1 | 0 | €4.09 | €6.03 | 47.300% |